Jennison Associates LLC Novo Nordisk A S Call Options Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,763Shares Held
340MCall Options Held
11.4MPut Options Held
15.5M-
Bank Of America Corp Charlotte, NC14.8MShares$988 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$827 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$793 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$749 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $151B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...